Detailed information for compound 155275

Basic information

Technical information
  • TDR Targets ID: 155275
  • Name: (2S)-2-[(5S)-1-[(2,6-dichlorophenyl)methyl]-2 -oxo-5-(3-phenylphenyl)-3,4-dihydro-1,4-benzo diazepin-5-yl]-2-(4,6-dimethylpyrimidin-2-yl) oxyacetic acid
  • MW: 653.554 | Formula: C36H30Cl2N4O4
  • H donors: 2 H acceptors: 5 LogP: 4.78 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 2
  • SMILES: Cc1nc(nc(c1)C)O[C@@H]([C@]1(NCC(=O)N(c2c1cccc2)Cc1c(Cl)cccc1Cl)c1cccc(c1)c1ccccc1)C(=O)O
  • InChi: 1S/C36H30Cl2N4O4/c1-22-18-23(2)41-35(40-22)46-33(34(44)45)36(26-13-8-12-25(19-26)24-10-4-3-5-11-24)28-14-6-7-17-31(28)42(32(43)20-39-36)21-27-29(37)15-9-16-30(27)38/h3-19,33,39H,20-21H2,1-2H3,(H,44,45)/t33-,36+/m1/s1
  • InChiKey: FHRCXZSDINFQMI-ILFWFZRHSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • (2S)-2-[(5S)-1-[(2,6-dichlorophenyl)methyl]-2-oxo-5-(3-phenylphenyl)-3,4-dihydro-1,4-benzodiazepin-5-yl]-2-(4,6-dimethylpyrimidin-2-yl)oxy-acetic acid
  • (2S)-2-[(5S)-1-[(2,6-dichlorophenyl)methyl]-2-oxo-5-(3-phenylphenyl)-3,4-dihydro-1,4-benzodiazepin-5-yl]-2-[(4,6-dimethyl-2-pyrimidinyl)oxy]acetic acid
  • (2S)-2-[(5S)-1-[(2,6-dichlorophenyl)methyl]-2-oxo-5-(3-phenylphenyl)-3,4-dihydro-1,4-benzodiazepin-5-yl]-2-(4,6-dimethylpyrimidin-2-yl)oxy-ethanoic acid
  • (2S)-2-[(5S)-1-(2,6-dichlorobenzyl)-2-keto-5-(3-phenylphenyl)-3,4-dihydro-1,4-benzodiazepin-5-yl]-2-(4,6-dimethylpyrimidin-2-yl)oxy-acetic acid

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Endothelin receptor Starlite/ChEMBL References
Homo sapiens endothelin receptor type B Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus granulosus pyroglutamylated rfamide peptide receptor Endothelin receptor   426 aa 412 aa 20.1 %
Echinococcus multilocularis pyroglutamylated rfamide peptide receptor Endothelin receptor   426 aa 412 aa 21.1 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi Smad1 0.0092 0.0199 0.0199
Onchocerca volvulus 0.0604 0.2698 0.5
Leishmania major isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.013 0.0386 1
Echinococcus granulosus tar DNA binding protein 0.1639 0.7748 1
Schistosoma mansoni tar DNA-binding protein 0.1639 0.7748 1
Brugia malayi MH2 domain containing protein 0.1344 0.6308 0.6308
Brugia malayi hypothetical protein 0.0604 0.2698 0.2698
Trypanosoma brucei isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.013 0.0386 1
Toxoplasma gondii isocitrate dehydrogenase 0.013 0.0386 1
Brugia malayi Calcitonin receptor-like protein seb-1 0.2101 1 1
Echinococcus multilocularis tar DNA binding protein 0.1639 0.7748 1
Loa Loa (eye worm) pigment dispersing factor receptor c 0.2101 1 1
Toxoplasma gondii isocitrate dehydrogenase 0.013 0.0386 1
Echinococcus multilocularis isocitrate dehydrogenase 2 (NADP+) 0.013 0.0386 0.0247
Loa Loa (eye worm) transcription factor SMAD2 0.1344 0.6308 0.6308
Brugia malayi TAR-binding protein 0.1639 0.7748 0.7748
Schistosoma mansoni NADP-specific isocitrate dehydrogenase 0.013 0.0386 0.0247
Loa Loa (eye worm) MH1 domain-containing protein 0.0092 0.0199 0.0199
Loa Loa (eye worm) hypothetical protein 0.2101 1 1
Echinococcus granulosus cadherin EGF LAG seven pass G type receptor 0.0665 0.2995 0.3703
Schistosoma mansoni hypothetical protein 0.0665 0.2995 0.3703
Loa Loa (eye worm) Smad1 0.0092 0.0199 0.0199
Loa Loa (eye worm) MH2 domain-containing protein 0.1344 0.6308 0.6308
Echinococcus multilocularis GPCR, family 2 0.0665 0.2995 0.3703
Brugia malayi isocitrate dehydrogenase 0.013 0.0386 0.0386
Schistosoma mansoni hypothetical protein 0.1436 0.6758 0.8688
Echinococcus granulosus NADP dependent isocitrate dehydrogenase 0.013 0.0386 0.0247
Loa Loa (eye worm) latrophilin receptor protein 2 0.0665 0.2995 0.2995
Echinococcus multilocularis cadherin EGF LAG seven pass G type receptor 0.0665 0.2995 0.3703
Schistosoma mansoni hypothetical protein 0.0665 0.2995 0.3703
Brugia malayi RNA binding protein 0.1639 0.7748 0.7748
Trypanosoma cruzi isocitrate dehydrogenase, putative 0.013 0.0386 1
Schistosoma mansoni tar DNA-binding protein 0.1639 0.7748 1
Plasmodium vivax isocitrate dehydrogenase [NADP], mitochondrial, putative 0.013 0.0386 1
Loa Loa (eye worm) MH2 domain-containing protein 0.0092 0.0199 0.0199
Brugia malayi MH1 domain containing protein 0.0092 0.0199 0.0199
Mycobacterium tuberculosis Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) 0.013 0.0386 0.5
Brugia malayi Latrophilin receptor protein 2 0.0665 0.2995 0.2995
Schistosoma mansoni tar DNA-binding protein 0.1639 0.7748 1
Schistosoma mansoni hypothetical protein 0.0665 0.2995 0.3703
Trypanosoma brucei isocitrate dehydrogenase, putative 0.013 0.0386 1
Brugia malayi latrophilin 2 splice variant baaae 0.1436 0.6758 0.6758
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.013 0.0386 0.0247
Schistosoma mansoni tar DNA-binding protein 0.1639 0.7748 1
Loa Loa (eye worm) TAR-binding protein 0.1639 0.7748 0.7748
Brugia malayi Isocitrate dehydrogenase 0.013 0.0386 0.0386
Loa Loa (eye worm) hypothetical protein 0.1436 0.6758 0.6758
Schistosoma mansoni tar DNA-binding protein 0.1639 0.7748 1
Echinococcus multilocularis diuretic hormone 44 receptor GPRdih2 0.0665 0.2995 0.3703
Echinococcus granulosus diuretic hormone 44 receptor GPRdih2 0.0665 0.2995 0.3703
Loa Loa (eye worm) hypothetical protein 0.0604 0.2698 0.2698
Brugia malayi calcium-independent alpha-latrotoxin receptor 2, putative 0.0665 0.2995 0.2995
Brugia malayi MH2 domain containing protein 0.0092 0.0199 0.0199
Echinococcus multilocularis isocitrate dehydrogenase 0.013 0.0386 0.0247
Echinococcus granulosus GPCR family 2 0.0665 0.2995 0.3703
Loa Loa (eye worm) RNA binding protein 0.1639 0.7748 0.7748
Loa Loa (eye worm) hypothetical protein 0.0665 0.2995 0.2995
Brugia malayi MH2 domain containing protein 0.0092 0.0199 0.0199
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.1639 0.7748 0.7748
Plasmodium falciparum isocitrate dehydrogenase [NADP], mitochondrial 0.013 0.0386 1
Loa Loa (eye worm) isocitrate dehydrogenase 0.013 0.0386 0.0386
Brugia malayi MH1 domain containing protein 0.0092 0.0199 0.0199
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.013 0.0386 0.0247
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.013 0.0386 0.0247
Schistosoma mansoni hypothetical protein 0.0665 0.2995 0.3703
Brugia malayi RNA recognition motif domain containing protein 0.1639 0.7748 0.7748
Trypanosoma cruzi isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.013 0.0386 1

Activities

Activity type Activity value Assay description Source Reference
ABC (functional) = 200 mmHg hr-1 In vivo area between curve (ABC) as calculated from the blood pressure recordings before and after administration of 30 mg/kg of the compound to hypertensiveDahl salt sensitive rats; number of rats=12 ChEMBL. 15139756
Duration of action (functional) = 18 hr Duration of action of compound for reducing the blood pressure of rats was determined ChEMBL. 15139756
IC50 (functional) = 16.9 nM Antagonist activity towards human recombinant Endothelin A receptor expressed in chinese hamster ovary (CHO) cells determined using [125I]-ET-1 as radioligand ChEMBL. 15139756
IC50 (functional) = 16.9 nM Antagonist activity towards human recombinant Endothelin A receptor expressed in chinese hamster ovary (CHO) cells determined using [125I]-ET-1 as radioligand ChEMBL. 15139756
IC50 (functional) = 25 nM Antagonist activity towards human recombinant Endothelin B receptor expressed in chinese hamster ovary (CHO) cells determined using [125I]-ET-1 as radioligand ChEMBL. 15139756
IC50 (functional) = 25 nM Antagonist activity towards human recombinant Endothelin B receptor expressed in chinese hamster ovary (CHO) cells determined using [125I]-ET-1 as radioligand ChEMBL. 15139756
Kd (functional) = 7.37 Inhibitory potency at native endothelin A and B receptors by inhibiting sarafotoxin Sf6 contractions of rat tracheal rings ChEMBL. 15139756
Kd (functional) = 8.98 Inhibitory potency of the compound at native endothelin A and endothelin B receptors by inhibiting endothelin-1 contractions of rat aortic rings ChEMBL. 15139756
Max effect (functional) = -15 mmHg Maximum effect of the compound on reduciton of mean arterial blood pressure was determined in rats ChEMBL. 15139756
pA2 (functional) = 7.37 Inhibitory potency at native endothelin A and B receptors by inhibiting sarafotoxin Sf6 contractions of rat tracheal rings ChEMBL. 15139756
pA2 (functional) = 8.98 Inhibitory potency of the compound at native endothelin A and endothelin B receptors by inhibiting endothelin-1 contractions of rat aortic rings ChEMBL. 15139756

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.